Recent research introduces a soft, injectable material designed for use in the eye to help protect and support damaged ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

Numbness in your legs can be caused by many health conditions, including peripheral neuropathy, a herniated disc, or nerve damage from an injury. The correct diagnosis can help you get the right ...

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...

The after-effects of a gastric bypass drove Penny Stadick to learn all she could about herbs and aromatherapy. Now the ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

CHELMSFORD, Mass. & NOVI, Mich. & DÜSSELDORF, Germany & TOKYO, July 02, 2025--Asahi Kasei Pharma has started trial drug administration in a Phase III study of ART-123 in Japan for CIPN.

Purpose: The epidemiology, classification, pathology, and treatment of diabetic neuropathy are reviewed. Summary: Diabetic peripheral neuropathy is a common complication of diabetes that can cause ...

Decades of research elucidating the pathophysiology of diabetic neuropathy have failed, thus far, to produce a treatment that prevents or reverses its development and progression. Recently ...